Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 12291
TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693834(US20240287046, Compound II-3)
Affinity DataIC50: 0.0600nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693821(US20240287046, Compound I-4)
Affinity DataIC50: 0.0600nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693820(US20240287046, Compound I-3)
Affinity DataIC50: 0.0620nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693833(US20240287046, Compound II-2)
Affinity DataIC50: 0.110nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693826(US20240287046, Compound I-9)
Affinity DataIC50: 0.132nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693824(US20240287046, Compound I-7)
Affinity DataIC50: 0.206nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693822(US20240287046, Compound I-5)
Affinity DataIC50: 0.220nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693832(US20240287046, Compound II-1)
Affinity DataIC50: 0.298nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693828(US20240287046, Compound I-11)
Affinity DataIC50: 0.323nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693818(US20240287046, Compound I-1)
Affinity DataIC50: 0.390nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693817(Ref: WO9632382 A1 1996-10-17 | US20240287046, Comp...)
Affinity DataIC50: 0.390nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693819(US20240287046, Compound I-2)
Affinity DataIC50: 0.421nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693825(US20240287046, Compound I-8)
Affinity DataIC50: 0.451nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693827(US20240287046, Compound I-10)
Affinity DataIC50: 1.14nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693830(US20240287046, Compound I-13)
Affinity DataIC50: 2.20nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM85050(SR142948A | CAS_184162-64-9 | SR 142948A | SR14294...)
Affinity DataIC50: 2.35nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693829(US20240287046, Compound I-12)
Affinity DataIC50: 2.89nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693831(US20240287046, Compound I-14)
Affinity DataIC50: 2.96nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM466500(US10799605, Example 5 | US20240287046, Compound C-...)
Affinity DataIC50: 4.46nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693823(US20240287046, Compound I-6)
Affinity DataIC50: 10.5nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent

TargetNeurotensin receptor type 1(Human)
Full-Life Technologies HK

US Patent
LigandPNGBDBM693814(US20240287046, in vitro binding assay ref | DOTA-N...)
Affinity DataIC50: 32.2nMAssay Description:The binding affinities of test compounds were determined by a radioligand competitive binding assay using 177Lu labeled C-1 as the reference radiolig...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
Go to US Patent